These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25623590)

  • 1. Transgenic mouse model expressing P53(R172H), luciferase, EGFP, and KRAS(G12D) in a single open reading frame for live imaging of tumor.
    Ju HL; Calvisi DF; Moon H; Baek S; Ribback S; Dombrowski F; Cho KJ; Chung SI; Han KH; Ro SW
    Sci Rep; 2015 Jan; 5():8053. PubMed ID: 25623590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies.
    de Latouliere L; Manni I; Iacobini C; Pugliese G; Grazi GL; Perri P; Cappello P; Novelli F; Menini S; Piaggio G
    Ann Anat; 2016 Sep; 207():2-8. PubMed ID: 26704357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice.
    Ye H; Zhang C; Wang BJ; Tan XH; Zhang WP; Teng Y; Yang X
    Oncogene; 2014 Oct; 33(43):5133-8. PubMed ID: 24213574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatile and enhanced tumour modelling in mice via somatic cell transduction.
    Rodriguez E; Mannion L; D'Santos P; Griffiths M; Arends MJ; Brindle KM; Lyons SK
    J Pathol; 2014 Mar; 232(4):449-57. PubMed ID: 24307564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
    Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
    J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of p53 null and gain-of-function mutations on salivary tumors in MMTV-Hras transgenic mice.
    Jiang D; Dumur CI; Massey HD; Ramakrishnan V; Subler MA; Windle JJ
    PLoS One; 2015; 10(2):e0118029. PubMed ID: 25695772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
    Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
    PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.
    Kasinski AL; Slack FJ
    Cancer Res; 2012 Nov; 72(21):5576-87. PubMed ID: 22964582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.
    Douchi D; Yamamura A; Matsuo J; Melissa Lim YH; Nuttonmanit N; Shimura M; Suda K; Chen S; Pang S; Kohu K; Abe T; Shioi G; Kim G; Shabbir A; Srivastava S; Unno M; Bok-Yan So J; Teh M; Yeoh KG; Chuang LSH; Ito Y
    Gastroenterology; 2021 Dec; 161(6):1907-1923.e26. PubMed ID: 34391772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mouse models for human colorectal cancer with liver metastasis].
    Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
    Kim KI; Park JH; Lee YJ; Lee TS; Park JJ; Song I; Nahm SS; Cheon GJ; Lim SM; Chung JK; Kang JH
    J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer.
    Morton JP; Timpson P; Karim SA; Ridgway RA; Athineos D; Doyle B; Jamieson NB; Oien KA; Lowy AM; Brunton VG; Frame MC; Evans TR; Sansom OJ
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):246-51. PubMed ID: 20018721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging.
    Ju HL; Ahn SH; Kim DY; Baek S; Chung SI; Seong J; Han KH; Ro SW
    PLoS One; 2013; 8(3):e59869. PubMed ID: 23555816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive monitoring of hepatocellular carcinoma in transgenic mouse with bioluminescent imaging.
    Park JH; Kim KI; Lee YJ; Lee TS; Kim KM; Nahm SS; Park YS; Cheon GJ; Lim SM; Kang JH
    Cancer Lett; 2011 Nov; 310(1):53-60. PubMed ID: 21741167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal.
    Zhao Z; Zuber J; Diaz-Flores E; Lintault L; Kogan SC; Shannon K; Lowe SW
    Genes Dev; 2010 Jul; 24(13):1389-402. PubMed ID: 20595231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Driven Pancreatic Cancer.
    Sun X; Yang D; Chen Y
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging.
    Hamstra DA; Bhojani MS; Griffin LB; Laxman B; Ross BD; Rehemtulla A
    Cancer Res; 2006 Aug; 66(15):7482-9. PubMed ID: 16885345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hCXCR1 transgenic mouse model containing a conditional color-switching system for imaging of hCXCL8/IL-8 functions in vivo.
    Zheng L; Njauw CN; Martins-Green M
    J Leukoc Biol; 2007 Nov; 82(5):1247-56. PubMed ID: 17704296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.